Grants and Contracts Details
Description
Abstract
The MIRAGE study is a retrospective, multicenter, observational cohort study of patients
with multidrug-resistant Pseudomonas aeruginosa infection treated with imipenem-
relebactam. Enrolling sites will collect EMR data and available bacterial isolates to
evaluate the clinical outcomes of adult patients. Data will be entered into a secure online
database (REDCap). Sites may enter up to 30 patients total. Available bacterial isolates will
be shipped to the Coordinating Center (U. of Pittsburgh) for antibiotic susceptibility testing
and identi?cation of mechanisms of resistance.
Status | Active |
---|---|
Effective start/end date | 9/1/23 → 8/31/25 |
Funding
- University of Pittsburgh: $2.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.